VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+35.03%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$893M
AUM Growth
+$893M
(-26%)
Cap. Flow
-$203M
Cap. Flow
% of AUM
-22.71%
Top 10 Holdings %
Top 10 Hldgs %
73.65%
Holding
46
New
3
Increased
4
Reduced
4
Closed
6
Top Buys
| 1 |
Aclaris Therapeutics
ACRS
|
$22M |
| 2 |
Cidara Therapeutics
CDTX
|
$18M |
| 3 |
DRUG
Bright Minds Biosciences
DRUG
|
$9.06M |
| 4 |
Delcath Systems
DCTH
|
$8.57M |
| 5 |
Trevi Therapeutics
TRVI
|
$7.73M |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$104M |
| 2 |
SVA
Sinovac Biotech, Ltd
SVA
|
$76.3M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$58.8M |
| 4 |
Viridian Therapeutics
VRDN
|
$13.3M |
| 5 |
ALX Oncology
ALXO
|
$7.34M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Soleno Therapeutics
SLNO
$3.6B
| $283M | 31.68% | 6,291,851 | – | – |
|
|
VRNA
2
Verona Pharma
VRNA
$9.16B
| $106M | 11.88% | 2,283,975 -1,265,783 | -36% | -$58.8M |
|
3
Geron
GERN
$893M
| $96.4M | 10.8% | 27,225,292 | – | – |
|
4
Terns Pharmaceuticals
TERN
$609M
| $38.2M | 4.28% | 6,895,746 | – | – |
|
|
AVDL
5
Avadel Pharmaceuticals
AVDL
$1.43B
| $28.2M | 3.16% | 2,684,109 | – | – |
|
6
Dyne Therapeutics
DYN
$1.92B
| $26.3M | 2.94% | 1,114,960 | – | – |
|
|
7
Aclaris Therapeutics
ACRS
$209M
| $22M | 2.47% | +8,888,888 | New | +$22M |
|
|
8
Delcath Systems
DCTH
$385M
| $20.6M | 2.3% | 1,708,579 +711,574 | +71% | +$8.57M |
|
|
9
Viridian Therapeutics
VRDN
$1.5B
| $18.8M | 2.11% | 982,576 -695,631 | -41% | -$13.3M |
|
|
10
Cidara Therapeutics
CDTX
$1.66B
| $18M | 2.02% | +670,600 | New | +$18M |
|
11
Erasca
ERAS
$445M
| $17M | 1.9% | 6,756,756 | – | – |
|
|
12
Trevi Therapeutics
TRVI
$883M
| $14.4M | 1.61% | 3,487,903 +1,875,000 | +116% | +$7.73M |
|
13
Astria Therapeutics
ATXS
$349M
| $13.9M | 1.56% | 1,552,685 | – | – |
|
14
Rezolute
RZLT
$619M
| $13.7M | 1.54% | 2,797,704 | – | – |
|
15
Sera Prognostics
SERA
$123M
| $13.4M | 1.51% | 1,650,440 | – | – |
|
16
Tourmaline Bio
TRML
$601M
| $12M | 1.34% | 591,882 | – | – |
|
17
Corvus Pharmaceuticals
CRVS
$428M
| $12M | 1.34% | 2,234,566 +737,298 | +49% | +$3.94M |
|
18
Instil Bio
TIL
$182M
| $11.2M | 1.25% | 585,485 -38,854 | -6% | -$742K |
|
19
Oric Pharmaceuticals
ORIC
$994M
| $10.3M | 1.16% | 1,277,818 | – | – |
|
20
Abeona Therapeutics
ABEO
$350M
| $10.3M | 1.15% | 1,842,751 | – | – |
|
|
ZBIO
21
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
| $9.69M | 1.09% | 1,183,260 | – | – |
|
|
DRUG
22
Bright Minds Biosciences
DRUG
$276M
| $9.06M | 1.02% | +251,572 | New | +$9.06M |
|
23
Olema Pharmaceuticals
OLMA
$375M
| $8.78M | 0.98% | 1,505,862 | – | – |
|
24
Cogent Biosciences
COGT
$1.69B
| $8.76M | 0.98% | 1,122,471 | – | – |
|
25
Celcuity
CELC
$2.17B
| $7.99M | 0.9% | 610,500 | – | – |
|